RADX logo

Radiopharm Theranostics Limited

RADX
Healthcare|Biotechnology|AU
$0.96
+0.07 (+7.85%)
Cash / Share
$0.35
Next Earnings Report
Feb 26, 2027
EPS est. -$1.05 · Revenue est. $699.3K
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest Sep 23, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases
Nov 4, 2026 · GlobeNewsWire
Radiopharm Theranostics Reports Business Update
Nov 2, 2026 · GlobeNewsWire
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
Sep 9, 2026 · GlobeNewsWire
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
Aug 26, 2026 · GlobeNewsWire
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
Aug 20, 2026 · GlobeNewsWire

SEC Filings (125)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 20266-KForeign issuer reportDocumentIndex
Oct 30, 20266-KForeign issuer reportDocumentIndex
Oct 27, 20266-KForeign issuer reportDocumentIndex
Oct 26, 20266-KForeign issuer reportDocumentIndex
Oct 20, 20266-KForeign issuer reportDocumentIndex
Oct 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 5, 20266-KForeign issuer reportDocumentIndex
Oct 1, 20266-KForeign issuer reportDocumentIndex
Sep 30, 202620-FAnnual report (foreign)DocumentIndex
Sep 30, 20266-KForeign issuer reportDocumentIndex
Sep 23, 2026EFFECTDocumentIndex
Sep 23, 2026424B3Offering prospectusDocumentIndex
Sep 22, 20266-KForeign issuer reportDocumentIndex
Sep 14, 20266-KForeign issuer reportDocumentIndex
Sep 14, 2026F-3Shelf registrationDocumentIndex
Sep 11, 20266-KForeign issuer reportDocumentIndex
Sep 9, 20266-KForeign issuer reportDocumentIndex
Sep 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 4, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Aug 28, 20266-KForeign issuer reportDocumentIndex
Aug 27, 20266-KForeign issuer reportDocumentIndex
Aug 26, 20266-KForeign issuer reportDocumentIndex
Aug 20, 20266-KForeign issuer reportDocumentIndex
Aug 17, 20266-KForeign issuer reportDocumentIndex
Aug 13, 20266-KForeign issuer reportDocumentIndex
Aug 3, 20266-KForeign issuer reportDocumentIndex
Jul 31, 20266-KForeign issuer reportDocumentIndex
Jul 28, 20266-KForeign issuer reportDocumentIndex
Jul 28, 20266-KForeign issuer reportDocumentIndex
Jul 27, 20266-KForeign issuer reportDocumentIndex
Jul 27, 2026424B5Offering prospectusDocumentIndex
Jul 24, 20266-KForeign issuer reportDocumentIndex
Jul 23, 2026424B5Offering prospectusDocumentIndex
Jul 22, 20266-KForeign issuer reportDocumentIndex
Jul 6, 20266-KForeign issuer reportDocumentIndex
Jun 30, 20266-KForeign issuer reportDocumentIndex
Jun 3, 20266-KForeign issuer reportDocumentIndex
May 1, 20266-KForeign issuer reportDocumentIndex
Apr 23, 20266-KForeign issuer reportDocumentIndex
Apr 20, 20266-KForeign issuer reportDocumentIndex